.Zevra Therapeutics' unusual illness drug seems to be to be on the pathway to permission this autumn...
.Pfizer's stage 3 Duchenne muscle dystrophy (DMD) genetics treatment failure has actually blown a $2...
.After more than twenty years of work with neurodegenerative ailments, Swiss biotech air conditioner...
.GSK has ditched a period 2 human papillomavirus (HPV) injection coming from its pipeline after maki...
.OS Therapies will definitely detail on the NYSE American stock substitution this morning through a ...
.ALX Oncology's phase 2 stomach cancer cells feedback cost has actually compromised. After finding i...
.Another of Ionis Pharmaceuticals' key midphase readouts has disappointed assumptions, causing the b...
.While Biogen's pharma peers are looking for late-stage assets along with little risk, chief executi...
.Instil Bio has actually been a biotech in search of a pipeline after it junked its lead resources o...
.Biogen has returned rights to a very early Alzheimer's illness plan to Denali Therapeutics, going o...